Alcon Total Assets 2019-2024 | ALC
- Alcon total assets for the quarter ending December 31, 2024 were $30.347B, a 2.48% increase year-over-year.
- Alcon total assets for 2024 were $30.347B, a 2.48% increase from 2023.
- Alcon total assets for 2023 were $29.614B, a 1.54% increase from 2022.
- Alcon total assets for 2022 were $29.165B, a 4.16% increase from 2021.
Alcon Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $30,347 |
2023 | $29,614 |
2022 | $29,165 |
2021 | $27,999 |
2020 | $27,600 |
2019 | $27,655 |
2018 | $27,062 |
Alcon Quarterly Total Assets (Millions of US $) |
|
---|---|
2024-12-31 | $30,347 |
2024-09-30 | $30,362 |
2024-06-30 | $29,718 |
2024-03-31 | $29,565 |
2023-12-31 | $29,614 |
2023-09-30 | $29,369 |
2023-06-30 | $29,209 |
2023-03-31 | $29,291 |
2022-12-31 | $29,165 |
2022-09-30 | $27,796 |
2022-06-30 | $27,727 |
2022-03-31 | $27,790 |
2021-12-31 | $27,999 |
2021-09-30 | $27,802 |
2021-06-30 | $27,750 |
2021-03-31 | $27,368 |
2020-12-31 | $27,600 |
2020-09-30 | $27,414 |
2020-06-30 | $27,481 |
2020-03-31 | $27,199 |
2019-12-31 | $27,655 |
2019-09-30 | $27,633 |
2019-06-30 | $27,774 |
2019-03-31 | $0 |
2018-12-31 | $0 |
2018-09-30 | $0 |
2018-06-30 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $48.486B | $9.911B |
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. |